Wenger Vieli acted as Swiss legal advisor to NLS Pharmaceutics on the deal. NLS Pharmaceutics completed the direct offering and concurrent private placement transaction with certain...
You must be a Standard 1 Year member to access this content.
Wenger Vieli acted as Swiss legal advisor to NLS Pharmaceutics on the issuance. NLS Pharmaceutics has completed the registered direct offering and concurrent private placement transaction with...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised sell-side in the sale transaction of EXALOS to indie Semiconductor advised by Kellerhals Carrard. EXALOS, a Swiss company specializing in high-performance optical semiconductors,...
You must be a Standard 1 Year member to access this content.
Homburger advised lead investors Atlantic Bridge Capital and OpenOcean on the deal. Wenger Vieli advised LatticeFlow. LatticeFLow AG, an ETH spin-off pioneering in robust artificial intelligence...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised NLS Pharmaceutics on the deal. NLS Pharmaceutics Ltd., a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised the shareholders of MENU Technologies Ltd on the deal. MENU has become part of the NYSE listed PAR Technology Corp. group. The MENU...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised NLS Pharmaceutics on the deal. NLS Pharmaceutics Ltd, a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised NLS Pharmaceutics on the deal. NLS Pharmaceutics Ltd, a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients...
You must be a Standard 1 Year member to access this content.
Homburger advised Credit Suisse (Switzerland) Ltd. in connection with the financing of the acquisition. Bär & Karrer acted as legal advisor to the sellers in this...
You must be a Standard 1 Year member to access this content.
VISCHER advised the sellers on this transaction. Wenger Vieli advised Atlas Antibodies. The shareholders of the evitria Group have sold the evitria Group to Atlas Antibodies,...
You must be a Standard 1 Year member to access this content.
